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Aims MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-tran-
scriptional level by either degradation or translational repression of a target mRNA. Encoded in the
genome of most eukaryotes, miRNAs have been proposed to regulate speciﬁcally up to 90% of human
genes through a process known as miRNA-guided RNA silencing. For the ﬁrst time, we sought to test
how myocardial ischaemia–reperfusion (IR) changes miR expression.
Methods and results Following 2 and 7 h of IR or sham operation, myocardial tissue was collected and
subjected to miRNA expression proﬁling and quantiﬁcation using a Bioarray system that screens for
human-, mice-, rat-, and Ambi-miR. Data mining and differential analyses resulted in 13 miRs that
were up-regulated on day 2, 9 miRs that were up-regulated on day 7, and 6 miRs that were down-regu-
lated on day 7 post-IR. Results randomly selected from expression proﬁling were validated using real-
time PCR. Tissue elements laser-captured from the infarct site showed marked induction of miR-21.
In situ hybridization studies using locked nucleic acid miR-21-speciﬁc probe identiﬁed that IR-inducible
miR-21 was speciﬁcally localized in the infarct region of the IR heart. Immunohistochemistry data show
that cardiac ﬁbroblasts (CFs) are the major cell type in the infarct zone. Studies with isolated CFs
demonstrated that phosphatase and tensin homologue (PTEN) is a direct target of miR-21. Modulation
of miR-21 regulated expression of matrix metalloprotease-2 (MMP-2) via a PTEN pathway. Finally, we
noted a marked decrease in PTEN expression in the infarct zone. This decrease was associated with
increased MMP-2 expression in the infarct area.
Conclusion This work constitutes the ﬁrst report describing changes in miR expression in response to IR
in the mouse heart, showing that miR-21 regulates MMP-2 expression in CFs of the infarct zone via a
PTEN pathway.
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1. Introduction
MicroRNAs (miRNAs) are small non-coding RNAs that regulate
gene expression at the post-transcriptional level by either
degradation or translational repression of a target mRNA.
Encoded in the genome of most eukaryotes, miRNAs have
been proposed to regulate speciﬁcally up to 90% of human
genes through a process known as miRNA-guided RNA silen-
cing.
1 Although miRNA studies predominate in the cancer
ﬁeld, little is known about their expression patterns or
role in other diseases, especially cardiovascular disorders.
Cardiac ischaemia leading to post-infarction heart failure
particularly in patients with large myocardial infarction is
associated with a high mortality. The mouse model of
acute myocardial infarction is commonly used to gain
mechanistic insight.
2 At present, there is no report on how
the miR genome responds to myocardial infarction.
Recently, we have demonstrated that miRNAs regulate the
angiogenic potential of endothelial cells by regulating
redox signalling.
3 This work constitutes the ﬁrst report
describing changes in global miR expression in response to
ischaemia–reperfusion (IR) in the mouse heart. Once the
list of IR-sensitive miRs in the myocardium was identiﬁed,
our goal was to utilize results from expression proﬁling to
develop a new paradigm in IR biology of the murine heart.
This is a particularly challenging task because although
the IR-sensitive miRs have hundreds of target genes for
each miR that have been predicted computationally, very
few have targets that have been biologically validated.
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 Our focus on miR-21 was based on the fact that a few target
genes for this miR have been biologically validated.
2. Methods
2.1 Survival model for coronary artery occlusion
and reperfusion
C57BL/6 (males, 10–12 weeks old) mice were subjected to IR of the
heart as described previously.
4–6 The studies were approved by the
Institutional Laboratory Animal Care and Use Committee of The Ohio
State University. The investigation conforms with the Guide for the
Care and Use of Laboratory Animals published by the US National
Institutes of Health. High-resolution (11.7 T) cardiac magnetic
resonance imaging was used to determine loss in cardiac function
following the IR insult
7 (see Supplementary material online,
Figure S1). The mice were killed 2 or 7 days after reperfusion.
Hearts were either collected frozen in OCT compound for laser
capture or in formalin for histological analyses. For microarray
analysis and real-time PCR, the hearts were snap frozen in liquid
nitrogen. For control, heart tissues were collected from
sham-operated mice. These mice were exposed to all surgical pro-
cedures except IR.
2.2 MicroRNA expression proﬁling and
quantiﬁcation
MiRNA expression proﬁling and quantiﬁcation was performed using
mirVanaTM miRNA Bioarray system (miRNA Bioarray V2, 1566V2,
Ambion, Austin, TX, USA). Details of the procedure and data analysis
are submitted as supplemental text (see Supplementary material
online, Table S4).
2.3 Quantiﬁcation of microRNA expression
Total RNA including the miRNA fraction was isolated using mirVanaTM
miRNA isolation kit, according to the manufacturer’s protocol
(Ambion). miRNA levels were quantiﬁed using speciﬁc Taqman
assays for miRNA (Applied Biosystems, Foster City, CA, USA) and
Taqman Universal Master Mix (Applied Biosystems). miRNA levels
were quantiﬁed with the 2
(2DDct) relative quantiﬁcation method
8
using miR-16 as the house-keeping miRNA.
2.4 miR/mRNA expression assay from
laser-captured microdissected heart samples
Laser microdissection and pressure catapulting (LMPC) was per-
formed using the Microlaser System from PALM Microlaser Technol-
ogies AG (Bernreid, Germany) as described.
5,9,10 Brieﬂy, murine
hearts subjected to IR were harvested, frozen in OCT compound,
and then cut into 10 mm sections using a cryo-microtome. The sec-
tions were placed on polyethylene napthalate membrane glass
slides (P.A.L.M. Microlaser Technologies AG; Bernreid), which had
been RNAZap (Ambion) and UV treated, for cutting and catapulting
as described by our group recently.
9,11 Sections were stained using a
modiﬁed haematoxylin QS procedure and the infarct site ident-
iﬁed.
9,12 Typical settings used for laser cutting were UV-Energy of
75–85 and UV-Focus of 70. Matched area (2   10
6 mm
2) of control
or non-infarct (NI) and infarct (I) areas were captured into 25 mL
of RNA extraction buffer (RNAqueousw-Micro Kit, Ambion). The
total RNA including the miRNA fractions was isolated using
QIAcube (Qiagen, Valencia, CA, USA) using RNeasy Mini Plus Protocol
with the gDNA eliminator columns and RNeasy Mini Spin column. The
quantiﬁcation of miRNA-21 was performed using Taqman assays for
miRNA as described in the previous section. Quantiﬁcation of
matrix metalloprotease-2 (MMP-2) was performed using real-time
PCR as described.
11
2.5 In situ hybridization
miR-21 was localized in mouse heart and subjected to IR using in situ
hybridization described previously.
13 In brief, the tissue was depar-
afﬁnized, treated with protease (2 mg/mL of pepsin for 30 min in
RNase free water), washed in sterile water, then treated with
100% ethanol, and air-dried. LNA-modiﬁed cDNA probes for miR-21
was used. The probes were labelled with the 30 oligonucleotide
tailing kit (Enzo Diagnostics, Farmingdale, NY, USA) using biotin as
the reporter nucleotide. Hybridization was performed at 378C over-
night and followed by a wash in 0.2  SSC and 2% bovine serum
albumin. The probe-target complex was seen due to the action of
alkaline phosphatase (as part of the streptavidin complex—Enzo
Diagnostics) on the chromogen nitroblue tetrazolium and bromo-
chloroindolyl phosphate. Nuclear fast red was used as the counter-
stain. The negative controls included: omission of the probe, use of
a scrambled LNA probe (the same sequence as the miR cDNA but
where the nucleotides have been ‘scrambled’ at random so that is
very low homology with the target sequence), and the internal
negative controls provided by each tissue section.
2.6 Cardiac ﬁbroblast isolation and culture
Experiments were performed using primary cardiac ﬁbroblasts (CFs)
isolated from adult (5–6 week old) mouse ventricle using procedures
described previously.
4,6 Experiments were performed under 5% O2
(in vivo normoxia for cardiac cells) conditions as described
before.
4–6,14
2.7 miRIDIAN miRNA inhibitor/mimic and siRNA
delivery
The cells were seeded (0.2   10
6 cells/plate in 35 mm plate)
in antibiotic-free medium for 24 h prior to transfection.
DharmaFECTTM 1 transfection reagent (Dharmacon RNA Technol-
ogies, Lafayette, CO, USA) was used to transfect cells with miRIDIAN
mmu-miR-21 inhibitor or miRIDIAN mimic-miR-21 (Dharmacon RNA
Technologies) for 72 h as per the manufacturer’s instructions. miRI-
DIAN miRNA inhibitor/mimic negative controls (Dharmacon RNA
Technologies) were used for control transfections. Samples were
collected after 72 h of miRNA inhibitor/mimic transfections for
quantiﬁcation of miRNA and protein expression. Phosphatase and
tensin homologue (PTEN) siRNA transfection was performed as
described.
5
2.8 Western blot
Western blot was performed using primary antibody against PTEN
(anti-PTEN, 26H9, Cell Signalling Technology, Inc., Danvers, MA,
USA) and p-AKT (anti-phospho AKT, Ser 473, Cell Signalling Technol-
ogy, Inc.) as described previously.
4,5,10
2.9 pGL3-PTEN-30-UTR luciferase reporter assay
mmu-miR-21 inhibitor or miRIDIAN mimic-miR-21 was transfected to
the cells followed by transfection with pGL3-PTEN-30-UTR ﬁreﬂy
luciferase expression construct together with Renilla luciferase
pRL-cmv expression construct using LipofectamineTM LTX PLUSTM
reagent (Invitrogen). Luciferase (Renilla and ﬁreﬂy) assays were
performed using the dual-luciferase reporter assay system
(Promega). Fireﬂy luciferase activity was normalized to Renilla luci-
ferase expression for each sample.
2.10 Histology
Formalin-ﬁxed parafﬁn-embedded or OCT-embedded frozen speci-
mens were sectioned. Immunohistochemical staining of sections
was performed as described earlier
10 using the following primary
antibodies: anti-vimentin (dil 1:200, clone V2009, Biomeda), anti-
muscle actin (dil. 1:50, clone HHF35, Dako Cytonation),
anti-alpha-sarcomeric actin (dil. 1:200, Abcam), and anti-PTEN
S. Roy et al. 22
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 (dil.1:100, Cell Signalling). Secondary antibody detection and coun-
terstaining were performed as described previously.
10
2.11 Statistics
In vitro data are reported as mean+SD of at least three exper-
iments. Comparisons among multiple groups were made by analysis
of variance. P , 0.05 was considered statistically signiﬁcant. For in
vivo studies, data are reported as mean+SD of at least four to six
animals.
3. Results
This study consists of two distinct components. The ﬁrst part
focuses on identifying, for the ﬁrst time, IR-sensitive miRNA
in the myocardium in vivo. This expression proﬁling com-
ponent represented a hypothesis-generating mission that
would provide results from unbiased interrogation of the
miR genome. The second part of this study is based on ﬁnd-
ings of the ﬁrst part where the functional signiﬁcance of
miR-21 in the ischaemia-reperfused myocardium was
addressed in a hypothesis testing scenario.
The experimental design and data analysis approach (see
Supplementary material online, Figure S2)o ft h i sw o r ka r e
basedonourpreviousstudiesontheanalysisofgeneexpression
proﬁling.
10,11 Here, a total of 661 miRs were screened using a
mirVana Bioarray V2 platform (http://www.ambion.com/jp/
techlib/resources/miRNA_array/Ambion_bioarray_1566V2_-
Jul06.xls).Thesebioarrayscontainprobestargetingacompre-
hensive selection of mouse miRNA from miRBase (Sanger
miRNA Registry: http://microrna.sanger.ac.uk) and a set of
novel, proprietary miRNA called Ambi-miR. The data analysis
approach identiﬁed a total of 4 miRs that were signiﬁcantly
and uniquely up-regulated at day 7 post-IR, 13 miRs that
were up-regulated at day 2 post-IR, and 6 miRs that were
uniquely down-regulated at day 7 post-IR (see Supplementary
material online, Figure S2A). With the objective to validate
the normalization approach used in this study, side-by-side
box plots of globally normalized log2 ratio of the expression
valuesforeachsamplewereplotted.
15Boxplotistypicallyrep-
resented by a box including a central lineand tail. The median
is represented by a red line in the box (see Supplementary
material online, Figure S2B). The ends of the box represent
theﬁrstandthirdquartilesofthedata,withtheboxcontaining
50% of the data. A point beyond the ends of the box on either
side is considered a mild outlier and red crosses represent
extreme outliers. The box plot illustratedas inSupplementary
materialonline, FigureS2 enables visualization of spatial vari-
ation among all samples following scaling and normalization.
The distribution of data among all arrays following normaliza-
tion was centred, thus validating the normalization approach
(see Supplementary material online, Figure S2). Hierarchical
clustering involves unsupervised sample clustering of candi-
date genes, obtained by appropriate analysis and ﬁltering, to
identify novel clusters that changed in a similar direction in
response to an experimental intervention.
16 Hierarchical
cluster image illustrating IR-sensitive miR induced or down-
regulated in the myocardial tissue is presented as in
Figure1A.miRsthatwerefoundtobesigniﬁcantlyup-ordown-
regulated in response to IR, compared with the results from
sham-operated mice, were subjected to hierarchical cluster-
ing. The following three major clusters were thus identiﬁed:
(i) miR up-regulated 7 days post-IR; (ii) miR up-regulated
2 days post-IR; and (iii) miR down-regulated 7 days post-IR.
AnnotationofmiRineachoftheclusterispresentedinTable 1.
Mining of the expression proﬁling data generated three
clusters of genes: up-regulated day 2 post-IR, up-regulated
Figure 1 miR expression proﬁling in hearts subjected to ischaemia–reperfusion. (A) Speciﬁc clusters of miR showing an increase or decrease in expression
following ischaemia (30 min) and reperfusion (2 or 7 days). miRs that were found signiﬁcantly up- or down-regulated in all replicates following ischaemia–
reperfusion (IR) compared with sham-operated samples were selected. These select candidates were subjected to hierarchical clustering to identify clusters
of miRs that were induced or down-regulated by ischaemia–reperfusion following 2 or 7 days post-ischaemia–reperfusion. (i) cluster of miR up-regulated speciﬁ-
cally 7 days post-ischaemia–reperfusion; (ii) cluster of miR up-regulated 2 days post-ischaemia–reperfusion; (iii) cluster of miR down-regulated speciﬁcally 7 days
post-ischaemia–reperfusion. Data shown are from four (1–4) individual animals. As is the standard, red to green gradation in colour represents higher to lower
expression signals. Annotations of miR in each of the cluster are presented in Table 1.( B) Expression levels of select miR identiﬁed using the proﬁling assay were
independently determined using real-time PCR. Real-time PCR data were normalized to miR-16. We chose miR-16 as the normalizing control because the
expression of this miR remained unchanged between sham and ischaemia–reperfusion groups. Those marked with a black arrow were veriﬁed using quantitative
assays. Data represent mean+SD (n ¼ 4). *P , 0.05 and **P , 0.01 compared with the corresponding sham samples.
miRNA in myocardial infarction 23
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 day 7 post-IR, and down-regulated day 7 post-IR. In the
cluster that was up-regulated 2 days post-IR, roughly half
(6 out of 13) of all the miRs were also found to be signiﬁ-
cantly higher on day 7 post-IR. Thus, this cluster had a
subset that was induced transiently, whereas the second
subset was found induced at both time-points examined.
For the cluster of miRs that were induced on day 7
post-IR, roughly half (ﬁve out of nine) were already
induced on day 2 post-IR. Therefore, this cluster demon-
strated the same pattern of subsets as noted for the 2-day
post-IR cluster discussed above. For the miR down-regulated
in response to IR, all but one showed signiﬁcant lowering on
day 7 post-IR. The remaining miR, rno_miR_327, was down-
regulated on day 2 post-IR (Table 1). To verify the accuracy
of miR expression proﬁling analyses performed, Taqman-
based real-time PCR analysis was performed on four candi-
date miRs (miR-21, miR-214, miR-379, and miR-146b)
randomly selected from Table 1. Quantitative real-time
PCR analyses of the individual miR provided results that
were consistent with microarray ﬁndings (Figure 1B).
Next, our goal was to utilize results from expression proﬁl-
ing to develop a new paradigm in IR biology of the murine
heart. Recently, we have developed novel technical capabili-
ties in LMPC, which enable the execution of high-resolution
laser capture and subsequent analyses from the myocardium
and vascular tissues.
9–12 Our results demonstrated that adop-
tionoftheLMPCapproach,asreportedbyourlaboratory,sub-
stantially improves the conﬁdence in detected changes in
gene expression in IR-affected tissue especially in mice
where the affected area is so small. Standard surgical tech-
niques do not allow exercise of a high level of stringency in
selectively collected IR-affected tissue while rejecting unaf-
fected tissue, resulting in dilution of the observation. Thus,
only major changes can be detected, whereas subtle
changes in gene expression stand the risk of getting masked
while using traditional surgical techniques for tissue
harvest.
10 LMPC is best suited to address this limitation.
9–12
Results of this study represent ﬁrst report of miRNA quanti-
tation from laser-captured tissue elements. We observed
that miR-21 is potently and speciﬁcally induced in the
infarct region, but not in the non-infarct tissue harvested
beyond 500 mm away from the infarct site (Figure 2). To
follow-up on the functional signiﬁcance of this observation,
itwasimportanttoknowwhetherthenotedmiR-21induction
was speciﬁc to any given cell type. As a result, in situ hybrid-
ization to detect miR-21 was performed using an LNA-based
approach. Cell-speciﬁc localization of miR-21 in heart sec-
tions was achieved with an LNA miR-21-speciﬁc probe. Inter-
estingly, we observed that miR-21 was indeed induced, but
only speciﬁcally in the infarct zone of the hearts subjected
Table 1 miRNAsigniﬁcantly (P , 0.05)changedinhearts subjected to ischaemia–reperfusion compared withsham-treatedhearts onday 2
or day 7 post-ischaemia–reperfusion
Post-IR day 2 (sham vs. IR) Post-IR day 7 (sham vs. IR)
Probe set Mean SD P Mean SD P
Cluster 1
hsa_miR_214
a 1.849 0.306 0.001 2.730 0.989 0.013
hsa_miR_199a 1.502 0.077 0.048 2.205 0.301 0.001
hsa_miR_379 1.059 0.120 0.533 1.845 0.443 0.011
hsa_miR_199a_AS 1.340 0.265 0.071 1.690 0.436 0.023
hsa_miR_31 1.327 0.199 0.045 1.683 0.260 0.003
mmu_miR_379
a 1.032 0.181 0.847 1.633 0.166 0.003
mmu_miR_199b 1.305 0.184 0.171 1.616 0.094 0.007
mmu_miR_31 1.296 0.056 0.000 1.599 0.269 0.006
hsa_miR_15b 1.554 0.237 0.022 1.365 0.117 0.004
Cluster 2
hsa_miR_223 3.664 0.253 0.000 1.329 0.214 0.143
hsa_miR_21
a 3.290 0.520 0.000 3.078 0.937 0.005
hsa_miR_146b
a 2.042 0.237 0.000 1.504 0.177 0.006
ambi_miR_13232 1.986 0.234 0.001 1.433 0.132 0.036
hsa_miR_491 1.978 0.170 0.000 1.558 0.255 0.007
hsa_miR_142_5p 1.902 0.459 0.016 1.378 0.242 0.025
hsa_miR_222 1.639 0.244 0.003 1.308 0.129 0.007
mmu_miR_106a 1.604 0.138 0.003 1.327 0.145 0.052
mmu_miR_20b 1.530 0.292 0.015 1.199 0.174 0.200
hsa_miR_17_5p 1.522 0.259 0.008 1.238 0.115 0.053
hsa_miR_20b 1.508 0.164 0.009 1.249 0.178 0.113
hsa_miR_106a 1.407 0.144 0.005 1.210 0.146 0.114
hsa_miR_221 1.370 0.086 0.001 0.990 0.113 0.922
Cluster 3
hsa_miR_499 21.602 0.607 0.146 21.639 0.191 0.003
rno_miR_499 21.217 0.211 0.273 21.638 0.459 0.022
hsa_miR_204 20.923 0.146 0.386 21.436 0.190 0.001
mmu_miR_207 20.969 0.126 0.626 21.412 0.154 0.011
hsa_miR_150 21.059 0.105 0.688 21.325 0.070 0.000
rno_miR_327 21.354 0.042 0.005 21.015 0.175 0.948
The corresponding cluster image is shown in Figure 1. Data presented indicate fold change (mean+SD) in miR expression.
aVeriﬁed by quantitative assays.
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 to IR (Figure 3). Vimentin immunostaining of a serial section
shows that CFs represent the major cell type of this zone
(Figure 3). The signal was not evident in the serial section
when the scrambled LNA miRNA probe was utilized
(Figure 3). miR-21-speciﬁc signal was not observed in non-IR
regions of the heart (Figure 3).
Figure 2 Induction of miR-21 in the infarct region of ischaemia-reperfused murine heart: a laser-capture microdissection based approach. C57BL/6 mice were
subjected to ischaemia (30 min) and reperfusion (IR). Heart samples were collected 7 days post-IR. (A) Frozen sections (10 mm) from collected heart samples
were stained with haematoxylin QS to histologically deﬁne the infarct (I) and control or non-infarct (NI) regions. These regions were subsequently cut and cap-
tured using laser-capture microdissection for miRNA expression analysis. (i) Representative images of heart tissue showing infarct (I) and control or non-infarct
(NI) areas following laser-capture microdissection compatible staining with haematoxylin QS; (ii) the identiﬁed area is marked; and (iii) laser-assisted cutting and
separation of the identiﬁed area for catapulting; (iv) the section after the marked area has been catapulted; Scale bar ¼ 150 mm. (B) The laser-captured tissue
elements from I and NI regions were used for quantiﬁcation of miR-21 expression using real-time PCR. Data represent mean+SD (n ¼ 4). **P , 0.01 compared
with control (NI) tissue.
Figure 3 Localization of miR-21 in ischaemia-reperfused mouse heart regions. Representative image showing localization of miR-21 in a section of a mouse
heart subjected to ischaemia for 30 min and reperfusion 7 days. Localization of miR-21 in heart sections was achieved using in situ hybridization analysis
with an LNA miR-21-speciﬁc probe. (A) miR-21 signal (blue) is evident in the infarct region (i). Fibroblast represented the major cell type in this region as ident-
iﬁed using immunohistochemical analysis with an anti-vimentin antibody (ii, brown) The miR-21 signal [as in (i)] was not evident in the serial section when the
scrambled LNA miRNA probe was utilized (iii). (B) Representative images from the non-infract region showing no or weak signal (blue) for miR-21 (i). The dis-
tribution of ﬁbroblasts and myocytes in this non-infarct (control) region was shown using anti-vimentin (ii, brown, ﬁbroblasts), or anti-muscle actin (iii
brown, myocytes) antibody immunohistochemical staining. Nuclear red fast (ISH) and haematoxylin (nuclear, blue, immunohistochemical) were used as counter-
stains. Scale bar¼50 mm. Additional higher magniﬁcation images of the infarct region for the ISH and immunohistochemical stains are also presented in Sup-
plementary material online, Figure S3.
miRNA in myocardial infarction 25
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 Although computational algorithms have predicted target
genes for speciﬁc miR, most such predictions remain to be
experimentally validated. PTEN has been recently identiﬁed
as a target for miR-21.
17 In addition, PTEN is the major phos-
phatase that has been recently linked to the biology of myo-
cardial IR injury as well as ischaemic preconditioning.
18
Furthermore, PTEN has been suggested to play a signiﬁcant
role in the regulation of cardiac ﬁbrosis.
19 Thus, we sought
to examine the signiﬁcance of miR-21 in regulating PTEN
in the CFs. Experiments were performed using primary CFs
isolated from adult (5–6 week old) mouse ventricle.
4,6
miR-21 levels in CFs were modulated by transfecting the
cells with miRIDIAN mmu-miR-21 inhibitor or mimic. These
miR inhibitors/mimics are single- or double-stranded RNA
oligonucleotides designed to inhibit or increase the function
of speciﬁc miRNAs. Oligonucleotides are chemically modi-
ﬁed to improve efﬁciency and biological stability. A negative
control miR inhibitor/mimic was used as control. Transfec-
tion of CFs with miR-21 inhibitor signiﬁcantly inhibited
miR-21 expression in these cells (Figure 4A). Likewise,
miR-21 mimic increased the expression of miR-21 in CFs
(Figure 4B). Inhibition of miR-21 in CFs resulted in an
increase in PTEN protein abundance (Figure 4C and D). To
assess whether PTEN is a direct target of miR-21 in CFs, a
fragment of the 30-UTR of PTEN mRNA containing the
putative miR-21-binding sequence cloned into a ﬁreﬂy luci-
ferase reporter construct was used. This construct was
co-transfected with a control Renilla luciferase reporter
construct into CFs along with control or miR-21-speciﬁc
inhibitor/mimic.
17 miR-21 inhibitor signiﬁcantly increased
the luciferase activity, whereas increasing miR-21
expression in CFs using mimic resulted in signiﬁcantly
decreased luciferase activity, demonstrating a direct and
inverse control of miR-21 on PTEN levels in CFs (Figure 4E
and F). These observations, for the ﬁrst time, identify a
direct role of miR-21 in regulating PTEN levels in CFs.
Work directed at understanding the signiﬁcance of PTEN
regulation by miR-21 in CFs led to the observation that
MMP-2 expression in CFs is regulated by miR-21 via a
PTEN-AKT-phosphorylation-dependentpathway.PTENknock-
down in CFs resulted in marked phosphorylation of Akt
(Figure 5A–C). Transfection of CFs with miR-21 mimic signiﬁ-
cantly increased MMP-2 expression (Figure 5D). This effect
was signiﬁcantly enhanced under conditions of PTEN knock-
down (Figure 5D). Taken together, these results demonstrate
that PTEN, an miR-21 target in CFs, negatively regulates Akt
phosphorylation. miR-21-dependent lowering of PTEN
results in Akt phosphorylation and induction of MMP-2.
Figure 4 Direct regulation of phosphatase and tensin homologue in cardiac ﬁbroblasts by miR-21. After isolation, cardiac ﬁbroblasts were cultured for 5 days.
The cells were transfected with miRIDIAN mmu-miR-21 inhibitor or miRIDIAN mmu-miR-21 mimic to down-regulate or increase miR-21 levels. (A and B) miR-21
expression levels in cardiac ﬁbroblasts 72 h post-transfection were determined using real-time PCR. miRIDIAN miRNA inhibitor/mimic negative controls were used
for control transfections. Mean+SD (n ¼ 4), *P , 0.01 compared with control-transfected cardiac ﬁbroblasts. (C) Phosphatase and tensin homologue protein
levels in cardiac ﬁbroblasts following knockdown of miR-21 in cardiac ﬁbroblasts. (D) Quantiﬁcation of phosphatase and tensin homologue level was performed
using densitometry. Data were normalized to GAPDH. Data shown represent mean+SD (n ¼ 3). *P , 0.01 compared with control-transfected cells. (E and F)T o
demonstrate that phosphatase and tensin homologue is a direct target for miR-21 in cardiac ﬁbroblasts, the cells were transfected with a pGL3-PTEN-30-UTR
ﬁreﬂy luciferase expression construct and co-transfected with pRL-TK Renilla luciferase expression construct along with either miR-21 inhibitor or mimic. An
increase in relative ﬁreﬂy luciferase activity in the presence of miR-21 inhibitor or a decrease in the presence of miR-21 mimic indicates that the 30-UTR of phos-
phatase and tensin homologue contains a target that is modulated by miR-21. Data represent mean+SD (n ¼ 3). *P , 0.05 compared with control-transfected
cells.
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 These results, combined with our observation that miR-21 is
expressed in the infarct zone of the IR heart (Figure 3A),
were in indirect agreement with our ﬁnding that PTEN
expression is lowered and MMP-2 expression is elevated in
the infarct region of the heart (Figure 6).
4. Discussion
Expression proﬁling of miR in a given disease paradigm rep-
resents a powerful approach for unbiased comprehensive
interrogation of the miR genome.
20,21 The ﬁrst expression
proﬁling of miR in the heart was reported only recently.
21
These studies aimed at examining heart failure and
cardiac hypertrophy. This report provides ﬁrst evidence
temporally characterizing global changes in murine myocar-
dial miRNA expression following IR.
The functional signiﬁcance of miR-21 largely depends on
the target genes that it regulates. Recently, PTEN has been
validated as a target gene for miR-21.
17 PTEN is a dual
protein–lipid phosphatase which dephosphorylates the sec-
ondary messenger produced by PI3K and interrupts the down-
streamactivationofAkt.
22Ofnoteinthecontextofthisstudy
is the observation that PTEN is implicated in ischaemic heart
diseases.
23 Therefore, the blocking of PTEN has been pro-
posed to be an important strategy to improve myocardial sur-
vivalfollowinganischaemicepisode.
19MMP-2hasemergedas
a key protease in various pathologies associated with oxi-
dative stress, including myocardial IR, heart failure, or
inﬂammation.
24 In the IR heart, MMP-2 directly contributes
to cardiac mechanical dysfunction.
25 Heart-speciﬁc trans-
genic MMP-2 directly impairs contractility
26 and causes mito-
chondrial dysfunction.
27 MMP-2 degrades the cytoskeletal
protein alpha-actinin in peroxynitrite-mediated myocardial
injury.
28 Findings of this study present ﬁrst evidence demon-
strating that in CFs, miR-21 negatively regulates PTEN
expression up-regulating phospho-Akt as well as MMP-2
expression. miR-21-induced MMP-2 expression was signiﬁ-
cantly increased in response to PTEN knockdown, directly
implicating PTEN in the inverse regulation of MMP-2
expression. This observation is consistent with previous
reports characterizing PTEN as a suppressor of MMP-2
expression.
29–31 The hypothesis that Akt induces MMP-2
expression is also supported by evidence from other exper-
imental systems.
32,33 While this work was in review, two
other publications have recognized the signiﬁcance of
miR-21 in the heart.
34,35 Changes in miR-21, speciﬁcally in
CFs, can regulate heart failure.
34 Another short report
noted the signiﬁcance of miR-21 in inﬂuencing myocardial
infarction outcomes.
35
Taken together, the current study presents ﬁrst evidence
documenting changes in miR expression following myocar-
dial IR in vivo. Comprehensive expression proﬁling was
Figure 5 miR-21 regulates MMP-2 expression in cardiac ﬁbroblasts via a PTEN-AKT-phosphorylation-dependent pathway. After isolation, cardiac ﬁbroblasts were
cultured for 5 days. The cells were transfected with phosphatase and tensin homologue siRNA. (A) Western blots of AKT phosphorylation and phosphatase and
tensin homologue expression in cardiac ﬁbroblasts following transfection of the cells with phosphatase and tensin homologue or control siRNA. b-actin was
used for data normalization. (B and C) Quantiﬁcation of p-AKTand phosphatase and tensin homologue levels were performed using densitometry. Data were nor-
malized to b-actin. Data represent mean+SD (n ¼ 3). *P , 0.05 compared with control siRNA-transfected cells. (D) MMP-2 expression in cardiac ﬁbroblasts trans-
fected with miR-21 mimic to increase miR-21 levels. MMP-2 expression in cardiac ﬁbroblasts was measured using real-time PCR. Data represent mean+SD (n ¼ 3).
*P , 0.05 compared with mimic control-transfected cells. (E) MMP-2 expression in cardiac ﬁbroblasts transfected either with miR-21 mimic or co-transfected with
phosphatase and tensin homologue siRNA. Data represent mean+SD (n ¼ 3). *P , 0.05 compared with mimic control-transfected cells.
#P , 0.05 compared with
miR-21 mimic þ control siRNA-transfected cells.
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 conducted to identify clusters of miRs that signiﬁcantly
changed in expression on days 2 and 7 post-IR. IR rapidly
induced miR-21 in the heart, and elevated miR-21 levels
were noted on day 7 post-IR as well. In the heart, miR-21
induction in response to IR was limited to CFs, where PTEN
was identiﬁed as a target gene for miR-21. The current ﬁnd-
ings indicate that IR-induced miR-21 limits PTEN function
and therefore causes activation of the Akt pathway and
increased MMP-2 expression in CFs of the infarct region of
the IR heart.
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Research online.
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